Stock & Company Details
Estrella Biopharma Inc $ESLA
Price:
N/A
N/A
43M
$18M
52 Week High:
N/A
10 Day Average Volume:
N/A
-1.18
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ESLA technical indicators
Latest Estrella Biopharma Inc (ESLA) indicator readings as of 2026-10-09.
ESLA's 14-day RSI is 25.7, in oversold territory. At $0.41 it is trading 60.8% below its 200-day moving average of $1.05, and below its 50-day average of $0.62. Price sits in the middle of its Bollinger Bands ($0.35 to $0.62). ADX reads 44.4, indicating a trending market.
Overview
Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.
Finance Bot
Ask your questions
Start by typing a question below.
